SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Jan 14
 +0.04 / +0.09%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month+1.04% 3 years+4.80%
3 months-7.66% 5 years+2.87%
1 year-17.54% Since inception+8.75%
Data through 01/15/2022

Quote Details

Previous close$44.06
Open day’s range43.39 – 44.16
Net asset value (NAV)44.13 (01/14/2022)
Daily volume62,204
Average volume (3 months)72,174
Data as of 4:00pm ET, 01/14/2022

Peer Comparisonvs. Health ETFs

Performance 5-yr return+2.87%+15.55%
Expense Gross exp ratio0.35%1.01%
Risk 5 year sharpe ratio0.240.85
Net assets$226.0M$2.3B
Average market cap$10.7B$36.4B
Average P/E17.222.1
Dividend / Share--0.29%


VHT Vanguard Health Care Index Fund ETF Shar...
RYH Invesco S&P 500® Equal Weight Health Ca...
FHLC Fidelity MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
LLY Eli Lilly and Co4.79%
PFE Pfizer4.73%
AVIR Atea Pharmaceuticals Inc4.70%
BMY Bristol-Myers Squibb4.68%
VTRS Viatris Inc4.51%
PRGO Perrigo Company PLC4.50%
OGN Organon & Co4.48%
MRK Merck4.46%
RPRX Royalty Pharma PLC4.46%
ZTS Zoetis Inc4.46%